News Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Market Closed - NSE India S.E. Other stock markets 05:12:31 30/04/2024 pm IST			5-day change	1st Jan Change
550.4 ^INR	+2.58%		+2.62%	+66.62%

18/04	Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	MT
17/04	Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	18/04	MT
Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit	17/04	MT
Shilpa Medicare Gets Board Nod to Launch QIP	09/04	MT
Shilpa Medicare's Life Science Arm Names CEO	28/03	MT
Shilpa Medicare's New Unit in Hyderabad, India Gets Zero Observations from US FDA	01/03	MT
Shilpa Medicare Gets Approval to Market Smoking Cessation Drug in Europe	26/02	MT
Transcript : Shilpa Medicare Limited, Q3 2024 Earnings Call, Feb 12, 2024	12/02
Shilpa Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02	CI
Shilpa Medicare Gets Germany's Marketing Approval for Rare Muscles Diseases Drug	19/01	MT
Shilpa Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11	CI
Shilpa Medicare Acquires US-Based Pilnova Pharma	03/11	MT
Shilpa Medicare Limited Launches Naturally Derived Option for the Treatment of Oral Mucositis in India Under the Brand Name Oraal	11/23/11	CI
Shilpa Medicare Unit's API Manufacturing Plant Gets Clearance from Japanese Drug Regulator's Inspection	04/23/04	MT
Shilpa Medicare Gets UK Drug Regulator's Nod to Market Drug for Meniere's Syndrome Symptoms	04/23/04	MT
Shilpa Medicare Limited Receives Marketing Authorization from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg	01/23/01	CI
Shilpa Medicare's Manufacturing Facility in Telangana Gets Clearance from Brazilian Regulator	25/23/25	MT
Transcript : Shilpa Medicare Limited, Q1 2024 Earnings Call, Aug 11, 2023	11/23/11
Shilpa Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/23/10	CI
Shilpa Medicare Limited Announces Issuance of Redeemable Non-Convertible Debentures for its 2 Wholly Owned Subsidiaries	08/23/08	CI
Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections	01/23/01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Summary

Filters